CAS: 119630-94-3 - NALOXONE BENZOYLHYDRAZONE
Fórmula:C26H27N3O4
InChI:InChI=1S/C26H27N3O4/c1-2-13-29-14-12-25-21-17-8-9-19(30)22(21)33-23(25)18(10-11-26(25,32)20(29)15-17)27-28-24(31)16-6-4-3-5-7-16/h2-9,20,23,30,32H,1,10-15H2,(H,28,31)/t20-,23+,25+,26-/m1/s1
Chave InChI:InChIKey=AKXCFAYOTIEFOH-RTOPKKFASA-N
SMILES:O=C(NN=C1CCC2(O)C3N(CC=C)CCC42C5=C(OC14)C(O)=CC=C5C3)C=6C=CC=CC6
- Sinónimos:
- Benzoic acid, 2-[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide
- Benzoic acid, [(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide
- N'-[(5β,6E)-3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5-epoxymorphinan-6-ylidene]benzohydrazide
- Naloxone Benzolyhydrazone K3 Opioid Rece Ptor Ag
- [(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-yliden]benzoic acid hydrazide
- [(5Α)-4,5-Epoxy-3,14-Dihydroxy-17-(2-Propenyl)Morphinan-6-Ylidene]Hydrazide Benzoic Acid
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
Benzoic acid, 2-[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide REF: IN-DA000PEFCAS: 119630-94-3 | 99.0% | 557,00 € | Qui 05 Dez 24 | |
Naloxone benzoylhydrazone REF: 7W-GP7396CAS: 119630-94-3 | - - - | A consultar | Ter 10 Dez 24 | |
Naloxone Benzoylhydrazone REF: 3D-UEA63094CAS: 119630-94-3 | Min. 95% | A consultar | Qui 16 Jan 25 | |
Naloxone benzoylhydrazone REF: TM-T12168CAS: 119630-94-3 | 98% | - - - | Produto descontinuado |
Benzoic acid, 2-[(5α)-4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-ylidene]hydrazide
Ref: IN-DA000PEF
1mg | 557,00 € |
Ref: 7W-GP7396
Tamanho indefinido | A consultar |
Naloxone Benzoylhydrazone
Produto ControladoRef: 3D-UEA63094
50mg | A consultar | ||
100mg | A consultar |
Naloxone benzoylhydrazone
Ref: TM-T12168
5mg | Descontinuado | Solicitar informações | |
10mg | Descontinuado | Solicitar informações | |
50mg | Descontinuado | Solicitar informações | |
100mg | Descontinuado | Solicitar informações |